Targeting the dopaminergic midbrain with precision 7-Tesla biofeedback training in depression: A proof-of-principle randomized controlled trial
Open Access
- 19 September 2026
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- p. 1-12
Abstract
The significant heterogeneity of major depressive disorder (MDD) requires the development of interventions that directly target underlying cognitive or neurobiological mechanisms. This work tested the efficacy of self-modulation of the dopaminergic midbrain with high-field 7-Tesla functional MRI biofeedback in a randomized, controlled, proof-of-principle trial that targeted motivation regulation. A total of N = 62 unmedicated participants (MDD and healthy controls) were randomized to receive either Active or Sham 7-Tesla functional MRI biofeedback and completed clinical assessments pre- and up to 30-days post-training. Factor analysis of clinical symptom change revealed a single latent clinical improvement factor that was significantly improved in the Active MDD compared to the Sham MDD group, immediately post-training (β = 15.85, t = 2.31, p = 0.03), and at 24-hours post-training (β = 22.84, t = 2.45, p = 0.02); effects were diminished and no longer significant at 7-day and 30-day follow-ups. Results of specific phenotypic clinical analysis revealed that depressed mood (F = 5.04, p = 0.029) and negative affect (F = 5.21, p = 0.027), but not positive affect, were most improved by the Active biofeedback intervention. Active biofeedback training engaged functional coupling over time between the VTA and the lateral frontal cortex in the MDD group (F = 6.03, p = 0.017), and greater overall VTA regulation was associated with clinical improvement (R = 0.268, p = 0.048). Together, these results indicate the potential utility of dopaminergic midbrain-based biofeedback training for improvement of mood and negative affect in MDD.Keywords
This publication has 76 references indexed in Scilit:
- Dorsolateral Prefrontal Cortex Drives Mesolimbic Dopaminergic Regions to Initiate Motivated BehaviorThe Journal of Neuroscience, 2011
- Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depressionDepression and Anxiety, 2009
- The STAR*D project results: A comprehensive review of findingsCurrent Psychiatry Reports, 2007
- Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasureSchizophrenia Research, 2007
- Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major DepressionApplied Psychophysiology and Biofeedback, 2007
- Neurofeedback for treating tinnitus2007
- Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical PracticeAmerican Journal of Psychiatry, 2006
- Control over brain activation and pain learned by using real-time functional MRIProceedings of the National Academy of Sciences, 2005
- Symptom-Based Predictors of a 10-Year Chronic Course of Treated DepressionJournal of Nervous & Mental Disease, 1999
- A Neural Substrate of Prediction and RewardScience, 1997